AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2021

Nov 1, 2021

30718_dirs_2021-11-01_ff1e0548-46d5-4169-a10a-feb48e8103cc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2021-10-28

Reporting Person: Bushman Julie L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-28	Common Stock	A	194	—	Acquired	674	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-28	Stock Option (right to buy)	$515.24	A	633	Acquired	2031-10-28	Common Stock (633)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$278.87	2030-07-31	Common Stock (361)	361	Direct
Stock Option (right to buy)	$255.69	2030-10-29	Common Stock (1507)	1507	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/28/2021) or the date of Bio-Techne's 2022 annual meeting of shareholders.